Latest Breaking News On - Egalet corporation zyla - Page 1 : comparemela.com

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. C. 20549 FORM 8-K CURRENT REPORT Pursuant to. -Today at 11:24 am- MarketScreener

United statesNew yorkPetera clemensCommission file numberAbuse deterrent pharmaExchange commissionSecurities exchangeName of each exchange on whichPfizer incZyla life sciencesDevelopment incLimitx technologyEgalet corporation zylaN north courtGrowth companyPharmaceuticals inc